Manipal Health Enterprises Ltd. operates a large network .

MANIPALHOS Strengths - Large hospital network: 49 hospitals and approximately 13,037 licensed beds across 14 states and union territories as of March 31, 2026. - Strong brand: Established reputation in multi-specialty and tertiary healthcare. - Diversified specialties: Cardiology, oncology, neurology, orthopaedics and renal sciences provide multiple revenue streams. - Revenue growth: FY2025–26 consolidated revenue increased 25.4% to ₹10,335.75 crore. 2. Weaknesses - High debt: Consolidated borrowings were approximately ₹11,185 crore as of May 2026. - Profit decline: FY2025–26 consolidated net profit declined 15.3% year-on-year to ₹916.59 crore despite revenue growth. - Acquisition-related costs: Expansion through acquisitions, particularly Sahyadri Hospitals, increases financing and integration requirements. - Occupancy potential: Occupancy was approximately 64.5% as of March 31, 2026, leaving scope to improve utilisation. 3. Opportunities - Healthcare demand growth: Rising income, ageing population and lifestyle diseases can increase demand for hospital services. - Sahyadri Hospitals acquisition: Integration of Sahyadri's network can expand geographical presence and create procurement and operational synergies. - Capacity expansion: New hospitals and additional beds can increase revenue-generating capacity. - High-value treatments: Oncology, cardiac surgery, robotic surgery and organ transplants offer 4. Threats - High competition: Apollo Hospitals, Fortis Healthcare and Max Healthcare compete for doctors, patients and premium healthcare services. - Regulatory risk: Changes in healthcare pricing regulations, insurance reimbursement and government policies can affect profitability. - Doctor retention: Competition for experienced doctors and specialist medical professionals can increase employee costs. - Acquisition integration risk: Delayed synergies or higher-than-expected integration costs could affect returns.